Key Points Question How common are payments from pharmaceutical companies and device manufacturers to gastroenterologists? Finding This cohort study of 15 497 gastroenterologists found that 86.9% received industry payments, with direct… Click to show full abstract
Key Points Question How common are payments from pharmaceutical companies and device manufacturers to gastroenterologists? Finding This cohort study of 15 497 gastroenterologists found that 86.9% received industry payments, with direct financial awards accounting for 62.7% of the total expenditures and 10 drugs accounting for 63.8% of the total payments. Twenty-nine of 36 recent guidelines included authors who had received industry payments. Meaning While mandated reporting of industry payments to physicians provides transparency, the practice remains common and may continue to affect the advice these physicians give to patients and peers.
               
Click one of the above tabs to view related content.